Nika Pharmaceuticals, Inc (NIKA) Retained Earnings (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Retained Earnings came in at $3.2 million in Q4 2023, little changed YoY from $3.2 million in Q4 2022, and little changed on a QoQ basis from $3.2 million in Q3 2023.
Nika Pharmaceuticals, Inc (NIKA) Retained Earnings (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Retained Earnings data on file, last reported at $3.2 million in Q4 2023.
- Quarterly Retained Earnings changed 0.0% year-over-year to $3.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.2 million (changed 0.0% YoY) and the FY2023 annual result came in at $3.2 million, changed 0.0% from the prior year.
- Retained Earnings steadied at $3.2 million in Q4 2023, from $3.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.3 million in Q3 2022 to a low of $88471.0 in Q4 2021.
- A 3-year average of $2.5 million and a median of $3.2 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 3550.34% — and 2023, when it slipped 2.74%.
- Tracing NIKA's Retained Earnings over 3 years: stood at $88471.0 in 2021, then surged by 3550.34% to $3.2 million in 2022, then changed by 0.0% to $3.2 million in 2023.
- The last three Retained Earnings figures came in at $3.2 million (Q4 2023), $3.2 million (Q3 2023), and $3.2 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 144,895.00 |
| Dec 31, 2021 | 88,471.00 |